Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Vallet

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Intensive Care Medicine|July 9, 2008
Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock?Fabrice Vallée, Benoit Vallet, Olivier Mathe, et al.
Intensive Care Medicine|December 6, 2013
Time course of central venous-to-arterial carbon dioxide tension difference in septic shock patients receiving incremental doses of dobutamineJihad Mallat, Younes Benzidi, Julia Salleron, et al.
European Journal of Anaesthesiology|May 6, 2011
EuSOS: European surgical outcomes studyRupert M Pearse, Andrew Rhodes, Rui Moreno, et al.
Intensive Care Medicine|March 21, 2002
Dobutamine and gastric-to-arterial carbon dioxide gap in severe sepsis without shockGilles Lebuffe, Bruno Levy, Rémy Nevière, et al.
Lancet (London, England)|February 5, 2013
Mortality after surgery in Europe - Authors' replyRupert Pearse, Rui P Moreno, Peter Bauer, et al.
Critical Care Medicine|December 16, 2004
Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsisWilliam L Macias, Benoit Vallet, Gordon R Bernard, et al.
Lancet (London, England)|September 25, 2012
Mortality after surgery in Europe: a 7 day cohort studyRupert M Pearse, Rui P Moreno, Peter Bauer, et al.
Critical Care Medicine|October 18, 2013
Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysisNeill K J Adhikari, R Phillip Dellinger, Stefan Lundin, et al.
Critical Care (London, England)|September 8, 2007
Cost-effectiveness of activated protein C in real-life clinical practiceJean-François Dhainaut, Stéphanie Payet, Benoit Vallet, et al.
Anesthesiology|December 28, 2002
Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgeryRolf Rossaint, Matthias Reyle-Hahn, Jochen Schulte Am Esch, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Intensive Care Medicine|July 9, 2008
Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock?Fabrice Vallée, Benoit Vallet, Olivier Mathe, et al.
Intensive Care Medicine|December 6, 2013
Time course of central venous-to-arterial carbon dioxide tension difference in septic shock patients receiving incremental doses of dobutamineJihad Mallat, Younes Benzidi, Julia Salleron, et al.
European Journal of Anaesthesiology|May 6, 2011
EuSOS: European surgical outcomes studyRupert M Pearse, Andrew Rhodes, Rui Moreno, et al.
Intensive Care Medicine|March 21, 2002
Dobutamine and gastric-to-arterial carbon dioxide gap in severe sepsis without shockGilles Lebuffe, Bruno Levy, Rémy Nevière, et al.
Lancet (London, England)|February 5, 2013
Mortality after surgery in Europe - Authors' replyRupert Pearse, Rui P Moreno, Peter Bauer, et al.
Critical Care Medicine|December 16, 2004
Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsisWilliam L Macias, Benoit Vallet, Gordon R Bernard, et al.
Lancet (London, England)|September 25, 2012
Mortality after surgery in Europe: a 7 day cohort studyRupert M Pearse, Rui P Moreno, Peter Bauer, et al.
Critical Care Medicine|October 18, 2013
Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysisNeill K J Adhikari, R Phillip Dellinger, Stefan Lundin, et al.
Critical Care (London, England)|September 8, 2007
Cost-effectiveness of activated protein C in real-life clinical practiceJean-François Dhainaut, Stéphanie Payet, Benoit Vallet, et al.
Anesthesiology|December 28, 2002
Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgeryRolf Rossaint, Matthias Reyle-Hahn, Jochen Schulte Am Esch, et al.
Pageof 7